SSEA Antibodies

Santa Cruz Biotechnology features a diverse variety of SSEA Antibodies for targeting stage-specific embryonic antigens (SSEA). Monoclonal SSEA Antibodies are effective tools in multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SSEA markers are essential for identifying and characterizing stem cells, particularly in relation to pluripotency and differentiation. Stage-specific embryonic antigens serve as key indicators in developmental processes, enabling researchers to track cellular changes and developmental stages. Understanding SSEA expression patterns helps advance knowledge in developmental biology and regenerative medicine applications. Studying SSEA markers provides valuable insights into stem cell maintenance, differentiation pathways, and cellular reprogramming. Research focusing on SSEA can enhance understanding of early embryonic development and stem cell biology. Santa Cruz Biotechnology monoclonal SSEA Antibodies support researchers worldwide in advancing stem cell research and potential therapeutic developments.